STAA Q1 2024 Earnings — STAAR Surgical Company Revenue & Financial Results | Market Cap Arena

STAASTAAR Surgical Company

$860M

Q1 2024 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$77M+5.2% YoY

Gross Profit

$61M78.9% margin

Operating Income

-$2M-2.9% margin

Net Income

-$3M-4.3% margin

EPS (Diluted)

$-0.07

QoQ Revenue Growth

+1.4%

Cash Flow

Operating Cash Flow

$22M

Free Cash Flow

$16M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$493M

Total Liabilities

$100M

Stockholders' Equity

$393M

Cash & Equivalents

$224M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$77M	$74M	+5.2%
Gross Profit	$61M	$58M	+6.0%
Operating Income	-$2M	$3M	-181.5%
Net Income	-$3M	$3M	-223.2%

Revenue Segments

Implantable Collamer Lenses

$77M100%

Other Surgical Products

$205,0000%